Skip to main content
Premium Trial:

Request an Annual Quote

Varian Shareholders OK Agilent Acquisition

NEW YORK (GenomeWeb News) – Varian today said that its shareholders have approved the firm's merger agreement with Agilent Technologies.

The deal, under which Agilent will acquire Varian for $52 per share in cash — for a total transaction value of around $1.5 billion — was announced in late July.

Varian said that shareholders representing approximately 84 percent of its outstanding stock voted in favor of the acquisition at a special meeting of stockholders held Oct. 5. The deal still remains subject to regulatory approvals and other closing conditions, and the firms expect to complete the transaction by the end of this year.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.